You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 301 No. 4, January 28, 2009 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related article
 •Related letters
 •Similar articles in JAMA
 Topic Collections
 •Cardiovascular System, Other
 •Cardiovascular System
 •Radiologic Imaging
 •Renal Diseases
 •Renal Diseases, Other
 •Statistics and Research Methods
 •Angiology
 •Drug Therapy
 •Adverse Effects
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Sodium Bicarbonate vs Sodium Chloride in Preventing Contrast Medium–Induced Nephropathy

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: We are concerned about possible confounding in the trial by Dr Brar and colleagues1 reporting that hydration with sodium bicarbonate was not superior to hydration with sodium chloride for the prevention of CIN in patients with moderate to severe chronic kidney disease who were undergoing coronary angiography. Nonsteroidal anti-inflammatory drugs (NSAIDs) are among the medications most frequently prescribed to elderly persons, especially for acute and chronic pain.2 Millions of patients use prescription NSAIDs daily, and half of these patients are older than 60 years and more susceptible to the adverse effects of NSAIDs.3 These medications inhibit the local vasodilatory effects of prostaglandins and may contribute to the effects of nephrotoxic contrast agents.4

In the study by Brar et al, patients were divided into 2 groups according to the preventive therapy modality, and Table 1 showed the characteristics of those groups. Although information about the proportions using some . . . [Full Text of this Article]

Mehmet Kanbay, MD
drkanbay@yahoo.com

Benan Kasapoglu, MD; Ali Akcay, MD
Department of Internal Medicine
Fatih University School of Medicine
Ankara, Turkey



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Sodium Bicarbonate vs Sodium Chloride for the Prevention of Contrast Medium–Induced Nephropathy in Patients Undergoing Coronary Angiography: A Randomized Trial
Somjot S. Brar, Albert Yuh-Jer Shen, Michael B. Jorgensen, Adam Kotlewski, Vicken J. Aharonian, Natasha Desai, Michael Ree, Ahmed Ijaz Shah, and Raoul J. Burchette
JAMA. 2008;300(9):1038-1046.
ABSTRACT | FULL TEXT  

RELATED LETTERS

Sodium Bicarbonate vs Sodium Chloride in Preventing Contrast Medium–Induced Nephropathy
William Burgess, Gregory J. Merten, and Robert A. Rittase
JAMA. 2009;301(4):377.
EXTRACT | FULL TEXT  

Sodium Bicarbonate vs Sodium Chloride in Preventing Contrast Medium–Induced Nephropathy
Bradley D. Shy, Amit Gupta, and Robert S. Hoffman
JAMA. 2009;301(4):377-378.
EXTRACT | FULL TEXT  

Sodium Bicarbonate vs Sodium Chloride in Preventing Contrast Medium–Induced Nephropathy
Alberto Bouzas-Mosquera, José M. Vázquez-Rodríguez, and Jesús Peteiro
JAMA. 2009;301(4):378-379.
EXTRACT | FULL TEXT  

Sodium Bicarbonate vs Sodium Chloride in Preventing Contrast Medium–Induced Nephropathy—Reply
Somjot S. Brar, Albert Yuh-Jer Shen, and Michael B. Jorgensen
JAMA. 2009;301(4):379-380.
EXTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2009 American Medical Association. All Rights Reserved.